Xenetic Biosciences (XBIO) Return on Sales (2023 - 2025)
Xenetic Biosciences' Return on Sales history spans 7 years, with the latest figure at 0.81% for Q4 2025.
- For Q4 2025, Return on Sales rose 88.0% year-over-year to 0.81%; the TTM value through Dec 2025 reached 0.95%, up 73.0%, while the annual FY2025 figure was 0.95%, 73.0% up from the prior year.
- Return on Sales reached 0.81% in Q4 2025 per XBIO's latest filing, down from 0.53% in the prior quarter.
- In the past five years, Return on Sales ranged from a high of 0.53% in Q3 2025 to a low of 2.48% in Q1 2024.
- Average Return on Sales over 3 years is 1.51%, with a median of 1.64% recorded in 2024.
- The largest YoY upside for Return on Sales was 106bps in 2024 against a maximum downside of -97bps in 2024.
- A 3-year view of Return on Sales shows it stood at 1.87% in 2023, then increased by 9bps to 1.69% in 2024, then soared by 52bps to 0.81% in 2025.
- Per Business Quant, the three most recent readings for XBIO's Return on Sales are 0.81% (Q4 2025), 0.53% (Q3 2025), and 1.23% (Q2 2025).